phase 3

May 6, 2021 | Maryam Shahzad

Novavax Initiates COVID-19 Vaccine Trials for Adolescents

Vaccine development company Novavax, headquartered in Gaithersburg, announced Monday that it expanded Phase 3 clinical trials for its COVID-19 vaccine candidate to include adolescents. The trials will include up to 3,000 youths ages 12-17 at up to 75 sites in the U.S., the company said in a press release. “Through the expansion of our PREVENT-19 […]

Read more

March 23, 2021 | Maryam Shahzad

Gayles: Counties Now Required to Follow State Vaccine Eligibility Phasing

The state issued a memo Monday that, effective immediately, directs entities providing COVID-19 vaccines to follow the state’s phasing for eligibility, Montgomery County Health Officer Dr. Travis Gayles said during a council meeting Tuesday. County health departments are included within those providers. Maryland moved to vaccination Phase 2 (2A) Tuesday, expanding eligibility to all residents […]

Read more

March 18, 2021 | Maryam Shahzad

Hogan Announces Maryland Will Enter Phase 2 Making Residents 60+ Eligible

Gov. Larry Hogan announced Thursday that Maryland will enter Phase 2 of its vaccination plan on Tuesday, March 23. Under Phase 2A, all residents ages 60+ will be eligible, Hogan said during a press conference Thursday. Effective immediately, all Marylanders ages 60+ can preregister for an appointment at a mass vaccination site. One week later […]

Read more

February 19, 2021 | Maryam Shahzad

Novavax to Provide 1.1 Billion COVID-19 Vaccine Doses Globally

Novavax, a vaccine development company headquartered in Gaithersburg, announced Thursday that it entered into a Memorandum of Understanding (MOU) with an international vaccine organization to provide more than 1 billion total doses of Novavax’s COVID-19 vaccine candidate, according to a statement from the company. Novavax will work with Gavi, the Vaccine Alliance to provide 1.1 […]

Read more

January 29, 2021 | Maryam Shahzad

Novavax’s Vaccine Candidate Shows Nearly 90% Efficacy in UK

Novavax, a vaccine development company headquartered in Gaithersburg, says its COVID-19 vaccine candidate showed 89.3% efficacy in UK clinical trials. The UK study enrolled more than 15,000 volunteers, according to a statement from Novavax on Thursday. More details will be released as data comes in, the company said. Phase 2b results in South Africa showed […]

Read more

January 15, 2021 | Maryam Shahzad

Novavax Looking for Volunteers for COVID-19 Vaccine Trials

Novavax, a vaccine development company headquartered in Gaithersburg, has initiated Phase 3 for its COVID-19 vaccine candidate.  It is the fifth candidate to reach Phase 3 in the U.S., after Pfizer, Moderna, AstraZeneca and Janssen. Novavax is looking for volunteers to participate in vaccine trials, particularly those who are part of at-risk populations like Hispanics, […]

Read more

January 14, 2021 | Maryam Shahzad

Hogan: Maryland Will Enter Vaccination Phase 1B Next Week 

Maryland will begin Phase 1B of its COVID-19 vaccination plan on Monday, Gov. Larry Hogan announced at a press conference Thursday. Phase 1B includes: – Residents ages 75+ – Residents in assisted/independent living, including behavioral health group homes/group homes for those with developmental disabilities – K-12 teachers and support staff, childcare providers Hogan also announced […]

Read more

October 21, 2020 | Maryam Shahzad

Maryland Releases Draft COVID-19 Vaccination Plan

Maryland released the initial draft of its COVID-19 vaccination plan. There are currently no coronavirus vaccines approved by the FDA. Referencing CDC information, the draft plan sent to CDC Director Robert Redfield on Oct. 16 said limited vaccine doses could be available by early November, but that is expected to increase considerably in 2021. Patients […]

Read more

September 24, 2020 | Maryam Shahzad

Hogan Tours Vaccine Development Company Novavax in Gaithersburg

On Thursday, Gov. Larry Hogan toured Novavax, a Gaithersburg company that is developing a COVID-19 vaccine. The vaccine candidate is currently in Phase 2 of clinical trials in the U.S., and is expected to begin Phase 3 in a few weeks. Novavax CEO Stanley Erck hopes to see results by early 2021, but said it’s […]

Read more

September 8, 2020 | Maryam Shahzad

Despite Elrich Request, Gayles Says Case Count Still Too High for Further Reopening

On Friday, Montgomery County announced that restaurants, breweries and wineries can offer live performances along with dining/drinking.  No dancing or congregating around performers is allowed, and people must wear masks (unless eating or drinking) and stay seated while eating. The announcement came shortly after most Maryland counties began Phase 3 of the state’s recovery. Phase 3 […]

Read more

Engage us on Facebook

Follow us on Twitter